These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23840699)

  • 1. Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress.
    Moujalled D; James JL; Parker SJ; Lidgerwood GE; Duncan C; Meyerowitz J; Nonaka T; Hasegawa M; Kanninen KM; Grubman A; Liddell JR; Crouch PJ; White AR
    PLoS One; 2013; 8(6):e67433. PubMed ID: 23840699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.
    Moujalled D; James JL; Yang S; Zhang K; Duncan C; Moujalled DM; Parker SJ; Caragounis A; Lidgerwood G; Turner BJ; Atkin JD; Grubman A; Liddell JR; Proepper C; Boeckers TM; Kanninen KM; Blair I; Crouch PJ; White AR
    Hum Mol Genet; 2015 Mar; 24(6):1655-69. PubMed ID: 25410660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS).
    Vaca G; Martinez-Gonzalez L; Fernandez A; Rojas-Prats E; Porras G; Cuevas EP; Gil C; Martinez A; Martin-Requero Á
    J Neurochem; 2021 Feb; 156(3):379-390. PubMed ID: 32628315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous Nuclear Ribonucleoprotein E2 (hnRNP E2) Is a Component of TDP-43 Aggregates Specifically in the A and C Pathological Subtypes of Frontotemporal Lobar Degeneration.
    Kattuah W; Rogelj B; King A; Shaw CE; Hortobágyi T; Troakes C
    Front Neurosci; 2019; 13():551. PubMed ID: 31213972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
    Parker SJ; Meyerowitz J; James JL; Liddell JR; Nonaka T; Hasegawa M; Kanninen KM; Lim S; Paterson BM; Donnelly PS; Crouch PJ; White AR
    PLoS One; 2012; 7(8):e42277. PubMed ID: 22879928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules.
    Hans F; Glasebach H; Kahle PJ
    J Biol Chem; 2020 Jan; 295(3):673-689. PubMed ID: 31780563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.
    Bhopatkar AA; Uversky VN; Rangachari V
    J Biol Chem; 2020 Feb; 295(8):2506-2519. PubMed ID: 31911437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression.
    Ayala YM; Misteli T; Baralle FE
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3785-9. PubMed ID: 18305152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.
    Nagata E; Nonaka T; Moriya Y; Fujii N; Okada Y; Tsukamoto H; Itoh J; Okada C; Satoh T; Arai T; Hasegawa M; Takizawa S
    Mol Neurobiol; 2016 Oct; 53(8):5377-83. PubMed ID: 26440668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs.
    Suzuki H; Shibagaki Y; Hattori S; Matsuoka M
    Hum Mol Genet; 2015 Mar; 24(6):1513-27. PubMed ID: 25378556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicity.
    Boyd JD; Lee P; Feiler MS; Zauur N; Liu M; Concannon J; Ebata A; Wolozin B; Glicksman MA
    J Biomol Screen; 2014 Jan; 19(1):44-56. PubMed ID: 24019256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
    Liu-Yesucevitz L; Bilgutay A; Zhang YJ; Vanderweyde T; Citro A; Mehta T; Zaarur N; McKee A; Bowser R; Sherman M; Petrucelli L; Wolozin B
    PLoS One; 2010 Oct; 5(10):e13250. PubMed ID: 20948999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropathology of TDP-43 proteinopathy].
    Akiyama H; Hasegawa M
    Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.